Thesis: Annealing commercial leader: record Q1 bookings (~33M), 100+ customers, a peer-reviewed useful-supremacy result — the one quantum name with an actual business — but lumpy revenue, big losses, and heavy insider selling into a drawdown; the survivor to watch first

Verdict: Research-only / watch, not a buy. This is a primary-source pass on D-Wave for a wider quantum-compute deep-dive program. QBTS earns a distinct tag the rest of the basket has not: it is the one quantum name with an actual commercial business — real bookings, real customers, real production workloads. That earns "the survivor to watch first" — not a perspective, not a trend-hold entry, and not a claim that D-Wave is ahead on general-purpose quantum computing. The house view on quantum stays skeptical-but-watching; QBTS is simply where we'd look first when it's time to look.

The Story Right Now

D-Wave is the quantum name that already sells something. While IONQ, RGTI, QUBT and the rest of our quantum-computing universe are effectively pre-revenue science projects, QBTS booked record Q1'26 bookings of $33.4M (up ~2,000% YoY) — a $20M Advantage2 system sale to Florida Atlantic University plus a $10M, two-year quantum-computing-as-a-service contract with a Fortune 100 customer. It reports 100+ customers in Q1'26 (>50% commercial enterprises), 100+ organizations running production workloads with measurable ROI across manufacturing, logistics, public safety and pharma, and customer usage +314% YoY. That is a commercial business, not a slide deck. It's the entire reason this name gets the "survivor" tag.

But say the important thing plainly: D-Wave is an annealing company — optimization and sampling — not universal gate-model quantum computing. Its commercial traction is real, but it lives in a narrower niche than the fault-tolerant, general-purpose machine the sector's biggest valuations are pricing. "Furthest along commercially" does not mean "ahead on general quantum computing." It means D-Wave found a real, paying corner of the problem space early and is monetizing it while the gate-model crowd is still pre-product. Those are different races; QBTS leads one of them, and it isn't the one most people mean when they say "quantum."

The numbers underneath are messy, and you have to read them in the right order. Revenue is lumpy — FY2025 was $24.6M, but Q1'26 product revenue was only $2.9M (YoY −81%), a swing driven entirely by system-sale timing, not a demand collapse (the demand signal is the $33.4M of bookings, which convert later). Losses are big: FY2025 operating loss −$100.4M, Q1'26 operating loss −$54.7M, with operating cash burn of $72M/yr. Ignore the headline net-income line — a positive net swing here is warrant/derivative mark-to-market noise, not operating profit; anchor on the operating loss, the burn, and the bookings. The balance sheet is the thing that buys time: **$588M of total liquidity** ($338.2M cash & equivalents + $250.2M short-term investments) at Q1'26.

The tape says wait. QBTS is $22.76, down −16.51% over the trailing 30 sessions (range $20.93–$31.30) — a drawdown, not the bottom→pop→flag→breakout setup our book actually buys. And the insider signal is loud: 1 buy / 56 sells, net −$331.1M — heavy distribution into that drawdown. Real business, real customers, real first-mover commercial lead in annealing — and still not a buy today. Lumpy revenue, large losses, insiders selling hard, tape bleeding. The fundamentals say "watch this one first"; the chart and the insiders say "not yet."

Setup

• Entry zone: watch-only; base above the $21 low, reclaim of $27 = first trigger
• Stop: $19
• Target: $31
• Conviction: low (research-only; the rating is about the setup and the insider/tape picture, not a knock on QBTS being the most commercial name in the basket).

Bull case

• It is the only quantum name with a real commercial business. 100+ customers, >50% commercial enterprises, 100+ orgs running production workloads with measurable ROI across manufacturing, logistics, public safety and pharma. Customer usage +314% YoY. This is the demand signal the rest of the basket can't show.
• Record bookings are the forward tell that revenue isn't. Q1'26 bookings $33.4M, up ~2,000% YoY — a $20M Advantage2 system sale (Florida Atlantic) and a $10M two-year QCaaS contract with a Fortune 100 customer. Bookings are the real demand signal here; the lumpy revenue line lags it.
• Advantage2 ships today. Annealing systems are commercial now, with customer applications already in production — not a roadmap promise contingent on future error-correction breakthroughs.
• A peer-reviewed useful-supremacy result. "Beyond-Classical Computation in Quantum Simulation" claims the first demonstration of quantum computational supremacy on a useful (materials-simulation) problem — a credibility marker most peers can't match.
• Liquidity buys years. ~$588M total liquidity against ~$72M/yr operating burn — no near-term dilution gun to the head while it grows the book.

Bear case

• Annealing is a narrower niche than the multiple implies. Optimization and sampling — not universal gate-model quantum computing. The commercial lead is real but in a specific problem class; it does not make QBTS the leader in general-purpose QC, which is what the sector's biggest valuations are pricing.
• Revenue is lumpy and small. FY2025 $24.6M; Q1'26 just $2.9M (−81% YoY) on system-sale timing. A revenue line that swings 80% on one deal's timing is hard to underwrite, and bookings only become revenue if/when they convert.
• Losses are large relative to revenue. FY2025 operating loss −$100.4M on $24.6M revenue; Q1'26 operating loss −$54.7M. The business is nowhere near self-funding.
• Insiders are selling hard. 1 buy / 56 sells, net −$331.1M — heavy distribution into a falling tape. The people closest to it are taking liquidity, not adding.
• The tape is a drawdown, not an uptrend. −16.51% over 30 sessions, range $20.93–$31.30. Our edge is buying confirmed uptrends; QBTS fails that test today. Beat-rate is a coin flip (50%) and the leading composite is Neutral (−0.3).
• House skepticism stands. Real business or not, quantum remains a late-cycle-AI option for us. Nothing here overturns the skeptical-but-watching stance — it just makes QBTS the first name to re-check.

Catalysts

• Bookings-to-revenue conversion (next prints): the $33.4M book has to show up as recognized revenue and smooth the lumpiness. This is the gate that could move QBTS from "watch" to "base-building."
• New Advantage2 system sales / QCaaS contracts: more deals like the FAU $20M and the Fortune-100 $10M validate that the commercial engine is repeatable, not one-off.
• Production-workload / customer-count expansion: continued growth past 100+ customers and the +314% usage trend confirms real adoption rather than pilots.
• Sector beta: quantum trades as a correlated basket on AI-cycle risk appetite; an IONQ/RGTI catalyst — or a science milestone like Google's Willow "Quantum Echoes" — drags QBTS with it regardless of D-Wave's own news.

Risks

• Net-income line is a trap, not a turn. Any positive net-income swing here is warrant/derivative mark-to-market noise, not operating profit. The real picture is the operating loss (−$54.7M Q1'26 / −$100.4M FY2025) and the ~$72M/yr cash burn. Do not read a green net line as profitability.
• Lumpy revenue can mask a soft quarter. Because one system sale can swing the top line 80%, a single delayed order looks like a collapse (and a single large order booked looks like a boom). Judge the trend on bookings + usage, not one quarter's revenue.
• Insider distribution is a genuine bearish tell. Unlike a de-SPAC artifact, 56 sells vs 1 buy (net −$331.1M) on an established issuer is real distribution — weigh it before any entry.
• Annealing ≠ the general-QC prize. The risk to the long-term story is that gate-model machines eventually subsume the optimization niche D-Wave owns today, leaving the commercial lead stranded in a shrinking corner.
• Dilution optionality. ~$588M is multi-year runway, but a company losing ~$100M/yr at the operating line will eventually tap markets; watch for raises into strength.

Financials

All figures code-/filing-sourced — edgar QBTS --facts (SEC EDGAR XBRL, CIK 0001907982), the 10-K / 10-Q, the Q1'26 results 8-K / investor release, and the trailing-30-session tape (price = Fri 2026-06-26 settled close). No prose math; anchor on operating loss + burn + bookings, not the net line.

Financials source: SEC EDGAR 10-K / 10-Q — income statement, balance sheet, and cash flow for QBTS (edgar QBTS --facts, CIK 0001907982).

Runway: at the ~$72M/yr operating cash burn, ~$588M of total liquidity ($338.2M cash & equivalents + $250.2M short-term investments) is multiple years of runway — no near-term dilution gun. But note the Q1'26 operating cash outflow was −$45.0M in a single quarter, so the burn is front-loaded and lumpy like the revenue; the clean run-rate needs a quarter or two of bookings converting. The solvency question isn't "can they survive," it's "can bookings turn into smooth revenue before the losses force a raise." That, not the balance sheet, is the thing to watch.

Cross-references

• Watchlist: already in quantum-computing (IONQ/RGTI/QBTS/QUBT/INFQ/…). Not held. No watchlist mutation — verdict is watch.
• Program: part of a wider quantum-compute deep-dive program (a filing-level pass per company). This is that pass for D-Wave/QBTS.
• Companion deep-dives (2026-06-28): INFQ (the rare revenue-generating sensing+compute name), IONQ, RGTI, QUBT — read QBTS against them: INFQ has sensing revenue, QBTS has annealing bookings/customers; both are "real-ish" for different reasons, the gate-model names are not yet.
• Sector science milestone: Google Willow "Quantum Echoes" (Oct 2025) — the gate-model supremacy headline that frames how narrow D-Wave's annealing useful-supremacy result is by comparison; different architecture, different race.
• No perspective opened — house view stays skeptical until a name earns one; this pass earns QBTS "the survivor to watch first," not a thesis.

Sources

• SEC EDGAR — D-Wave Quantum Inc. (CIK 0001907982): filings index — 10-K (2026-02-26), 10-Q (2026-05-12), 8-K (2026-06-18).
• D-Wave Q1'26 results — record $33.4M bookings, 100+ customers (8-K / investor release, StockTitan)
• D-Wave investor relations / news (dwavequantum.com)
• "Beyond-Classical Computation in Quantum Simulation" — D-Wave useful-supremacy paper (peer-reviewed; materials-simulation problem).